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Background: Chronic heart failure accounts for approximately 1%-2% of health care expenditures in most developed countries.
These costs are primarily driven by hospitalizations and comorbidities. Telemonitoring has been proposed to reduce the number
of hospitalizations and decrease the cost of treatment for patients with heart failure. However, the effects of telemonitoring on
health care utilization remain unclear.
Objective: This systematic review aims to study the effect of telemonitoring programs on health care utilization and costs in
patients with chronic heart failure. We assess the effect of telemonitoring on hospitalizations, emergency department visits, length
of stay, hospital days, nonemergency department visits, and health care costs.
Methods: We searched PubMed, Embase, and Web of Science for randomized controlled trials and nonrandomized studies on
noninvasive telemonitoring and health care utilization. We included studies published between January 2010 and August 2020.
For each study, we extracted the reported data on the effect of telemonitoring on health care utilization. We used P<.05 and CIs
not including 1.00 to determine whether the effect was statistically significant.
Results: We included 16 randomized controlled trials and 13 nonrandomized studies. Inclusion criteria, population characteristics,
and outcome measures differed among the included studies. Most studies showed no effect of telemonitoring on health care
utilization. The number of hospitalizations was significantly reduced in 38% (9/24) of studies, whereas emergency department
visits were reduced in 13% (1/8) of studies. An increase in nonemergency department visits (6/9, 67% of studies) was reported.
Health care costs showed ambiguous results, with 3 studies reporting an increase in health care costs, 3 studies reporting a
reduction, and 4 studies reporting no significant differences. Health care cost reductions were realized through a reduction in
hospitalizations, whereas increases were caused by the high costs of the telemonitoring program or increased health care utilization.
Conclusions: Most telemonitoring programs do not show clear effects on health care utilization measures, except for an increase
in nonemergency outpatient department visits. This may be an unwarranted side effect rather than a prerequisite for effective
telemonitoring. The consequences of telemonitoring on nonemergency outpatient visits should receive more attention from
regulators, payers, and providers. This review further demonstrates the high clinical and methodological heterogeneity of
telemonitoring programs. This should be taken into account in future meta-analyses aimed at identifying the effective components
of telemonitoring programs.
(J Med Internet Res 2021;23(9):e26744) doi: 10.2196/26744
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Chronic heart failure (CHF) is one of the most prevalent
high-cost chronic diseases affecting at least 1%-2% of the
worldwide population [1]. Europe and the United States spent
approximately 1%-2% of their national health care budget on
this chronic disease [1,2]. Worldwide, the economic burden of
CHF is estimated to be approximately US $108 billion per
annum, of which US $65 billion can be attributed to direct health
care costs [2]. CHF is characterized by an erratic and
difficult-to-predict course. A high percentage of incurred costs
are due to high readmission rates, as well as the high number
of comorbidities [3].
Changes in physiological parameters such as weight, heart rate,
blood pressure, and pulse oximetry may precede cardiac events.
Signaling such changes through telemonitoring may enable
physicians to intervene before the patient needs hospitalization
or an emergency department (ED) visit [4]. Telemonitoring has
been proposed as a possible strategy to tackle the challenges
that CHF brings to health systems, most notably, spare use of
the utilization of expensive resources. Telemonitoring has the
potential to prevent hospital readmissions, thereby saving costs
and improving the quality of life of these patients [5].
The technology and quality of care for patients with CHF have
been evolving, which has resulted in a variety of telemonitoring
programs consisting of different elements for different
populations. In addition, studies on the effect of telemonitoring
on health care utilization differ widely according to
cointerventions, time horizons, and outcome measures. Such
parameters may affect the effectiveness of telemonitoring and
the comparability of studies [6]. This heterogeneity at many
levels results in debates concerning the effectiveness of
telemonitoring.
Studies on telemonitoring have shown mixed results with respect
to health care utilization. Although some studies showed a
decline, others showed no significant differences or even an
increase in health care utilization. Many studies have included
cointerventions within the telemonitoring intervention.
Structured telephone support (STS) has often been incorporated
[7-9]. As STS has been reported to reduce the number of heart
failure–related hospitalizations [10], the effects found in studies
that use these two interventions simultaneously may not be
solely attributed to the telemonitoring program. A Cochrane
study from 2015 [10] concluded that, although telemonitoring
can reduce heart failure–related admissions, telemonitoring
programs were not able to reduce the risk of all-cause
hospitalization. A variety of systematic reviews have been
performed, mostly exclusively including randomized controlled
trials (RCTs). Bashi et al [11] performed an overview of
systematic reviews and found that 11 of 19 systematic reviews
only included RCTs. Although RCTs are considered as the gold
standard for research purposes, observational studies also have
merits that should not be ignored. For example, they provide a
sense of the real world as opposed to experimental RCT settings
[12]. Especially for diseases such as heart failure, which is
known for a high degree of multimorbidity [13], RCTs may be
limited by their strict inclusion and exclusion criteria. In
addition, the vast majority of previous systematic reviews have
only analyzed the effect of telemonitoring on hospitalizations
and mortality [10,11]. Thus, limited information is available on
the effect of telemonitoring programs on other outcomes, such
as ED visits, length of stay, and other forms of health care
utilization.
Objective
We therefore performed a systematic review on the effect of
telemonitoring for CHF on health care utilization, including
both RCTs and observational studies. By including a wide
variety of telemonitoring programs and outcome measures, we
aim to identify the various aspects and broad impact of




PubMed, Web of Science, and Embase (Ovid) databases were
searched. All authors were consulted for additional eligible
studies. A detailed description of our search strategy for each
database can be found in Multimedia Appendix 1. We excluded
articles published before January 1, 2010 because technology
and insights have rapidly evolved over the past 10 years. Our
search was updated until August 4, 2020 according to the
method described by Bramer [14]. Removal of duplications was
performed according to the method described by Bramer et al
[15].
Eligibility Criteria
Telemonitoring includes a wide variety of definitions and
descriptions. Generally, telemonitoring refers to the use of
telecommunication to assist in the transmission of medical
information and services between health care providers and
patients [16]. This definition also includes STS. Many studies
do not explicitly distinguish between invasive and noninvasive
telemonitoring techniques. However, this review explicitly
focuses on noninvasive techniques exclusively because there
are significant differences between implanted monitoring
devices and noninvasive telemonitoring in terms of costs and
eligibility of patients [17]. Thus, we defined telemonitoring as
the noninvasive application– or web-based collection and
transfer of physiological data, aimed at improving quality of
life or decreasing health care utilization in patients with heart
failure, or both.
We included peer-reviewed studies that reported direct or
indirect measurements of health care utilization such as
hospitalizations, ED visits, length of stay, days of
hospitalization, visits, and health care costs. We did not apply
exclusion parameters concerning study design to include all
available evidence. Therefore, we included RCTs,
nonrandomized trials, and studies on observational data.
However, we excluded studies that were not based on original
data such as Markov models because these studies are based on
assumptions rather than empirical data. Studies with regular
telephone support initiated by nurses or health care providers
(without medical indication) were excluded to focus on the
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effect of telemonitoring as opposed to the combined effect of
telemonitoring and STS. We excluded studies from countries
not belonging to the Organization for Economic Co-operation
and Development to improve homogeneity in terms of the
socioeconomic characteristics of the populations. Finally, studies
that were not published in either English or Dutch were included.
Textbox 1 presents the inclusion and exclusion criteria.
Textbox 1. Inclusion and exclusion criteria.
Inclusion criteria
• Telemonitoring equipment within program assessed physiological parameters.
• Telemonitoring measures were shared with at least one health care provider.
• Patients are living independently and are allowed to have access to home care services but should not be admitted to a nursing home during the
intervention.
• Subjects have been diagnosed with chronic heart failure.
• Outcomes included direct or indirect measures of health care utilization.
• Paper was a peer-reviewed publication.
Exclusion criteria
• Study was performed in countries not belonging to the Organization for Economic Co-operation and Development.
• Publication date was before January 1, 2010.
• Telemonitoring program included structured telephone support.
• Intervention program used invasive telemonitoring (eg, CardioMEMS).
• Study was not available in the English or Dutch language.
• No quantitative data with accompanied statistical analysis or measure of statistical significance was reported.
• Health care utilization measure was not reported separately (eg, combined end point with death).
Study Selection and Data Extraction
Titles and abstracts were independently screened by 2
researchers (SLA and TEPR) for eligibility. In cases where no
conclusive decision could be made, studies were included for
full-text screening. Full-text screening was performed in
duplicate and independently by SLA and TEPR. Disagreements
were resolved by discussion until consensus was achieved or
consultation with a coauthor (RBK or SAVD). Thereafter, data
were extracted by one researcher (SLA) for both CHF-specific
health care utilization and all-cause utilization because a
reduction in CHF-specific health care utilization may not
translate into an overall reduction [10]. For each study, the effect
of telemonitoring on health care utilization was determined by
extracting data on hospitalizations, ED visits, length of stay,
days of hospitalization, visits, and health care costs. We
determined the statistical significance of these results using a
cut-off value of P<.05. If no P value was reported, we deemed
the effect statistically significant if the reported CI did not
include 1.00.
Risk of Bias Assessment
The risk of bias assessment was performed by SLA and TEPR.
For the risk of bias assessment, we used the Cochrane
risk-of-bias tool for randomized trials [18] and Risk of Bias in
Non-randomized Studies of Interventions tools (Cochrane) [19]
for RCTs and all remaining studies, respectively. The studies
were assessed in duplicate and independently. Subsequently,
the individual assessments were compared for possible
discrepancies. When discrepancies were observed, the studies




Our search strategy identified 3770 unique studies, which were
then screened in the title and abstract. This resulted in 99
remaining studies. After the full-text screening, 29 studies were
included. Figure 1 shows the flow diagram. The main reason
for exclusion after full-text screening was because STS was a
part of the intervention (19/70, 27%), followed by a lack of
measuring and transmitting physiological parameters in the
program (17/70, 24%). Most studies (11/29, 38%) originated
in the United States.
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Figure 1. PRISMA (Preferred Reported Items for Systematic Reviews and Meta-Analyses) flowchart. OECD: Organization for Economic Co-operation
and Development.
Characteristics of Included Studies
Table 1 presents an overview of study and program
characteristics. A detailed description of the studies and their
characteristics are presented in Table 2. Telemonitoring
programs showed a high degree of heterogeneity in terms of
physiological variables measured as shown in Multimedia
Appendix 2 [4,20-47]. All studies included weight as a
parameter, whereas only 4 included electrocardiography
measures as a physiological parameter [20-23]. The studies used
10 unique combinations of physiological parameters. In addition,
2 studies included other measures such as lung fluid [24] and
body composition [25], which were acquired by noninvasive
means. Most programs (n=16) used telemonitoring in addition
to usual care; regular check-up visits were still scheduled
[4,22,24,26-38]. One study [20] stated that telemonitoring was
used as a substitute for these visits, and 12 studies did not
elaborate on this matter. The follow-up period of the studies
ranged between 1 and 89 months, with most studies having a
follow-up period of 6 months. Follow-up was consistent with
the duration of the telemonitoring program itself, with the
exception of 2 studies that also included a follow-up after the
telemonitoring program was completed [24,39].
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Table 1. Overview of the characteristics of included studies (N=29).
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aNYHA: New York Heart Association.




fRCT: randomized controlled trial.
gTEMA-HF: Telemonitoring in the Management of Heart Failure.
Patient inclusion criteria for previous hospitalizations differed
among the studies. If a hospital admission was required for
inclusion, this was most often (n=10) within 7 days of discharge
[4,23,24,29,35,37,39-42]. Inclusion was started within 1 month
of index hospitalization for 2 studies [20,25], and 5 studies
[21,32,43-45] included patients within 6 months. Most studies
(n=12) [22,26-28,30,31,33,34,36,38,46,47] did not specify
requirements regarding previous admissions for CHF or included
patients from outpatient clinics. New York Heart Association
(NYHA) Class II was most often reported (n=9) as the NYHA
Classification with most patients [21,22,25,26,28,32,38,45,46].
NYHA Class III was reported in 8 studies as the dominant class
[20,23,29,31,35,43,44,47].
Risk of Bias Assessment
We found that most RCTs (12/16, 75%) showed at least some
bias concerns, with 2 RCTs having a high risk of bias [21,27].
The main reasons for some concerns in the RCTs were related
to the randomization process. In addition, 75% (9/12) of
nonrandomized studies were assessed as having a serious or
critical risk of bias. No nonrandomized studies were assessed
as having a low risk of bias, which indicates that the strength
of evidence from none of the included nonrandomized studies
is equivalent to a well-performed RCT [19]. Bias due to
confounding was the domain that most often resulted in studies
being assessed with a serious or critical risk for bias. Table 3
shows the consolidated overall bias assessments. A detailed
overview of the risk of bias assessment of all studies can be
f o u n d  i n  M u l t i m e d i a  A p p e n d i x  3
[20-23,25-27,29,31-33,39,43,44,46,47] and Multimedia
Appendix 4 [4,24,28,30,34-38,40-42,45].
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Table 3. Summary of risk of bias assessment for randomized controlled trials and nonrandomized studies.
Result of bias risk assessmentStudy
Randomized controlled trialsa
Some concernsDelaney (2013) [43]
Some concernsDendale (2014) [44]
Some concernsDomingo (2011) [26]
High riskHoban (2013) [27]
Low riskKotooka (2018) [25]
Low riskKraai (2016) [20]
Some concernsLyngå (2012) [29]
Low riskFrederix (2018) [39]
High riskOlivari (2018) [21]
Some concernsPedone (2015) [31]
Some concernsSeto (2012) [22]
Some concernsSoran (2010) [32]
Some concernsTompkins (2012) [33]
Low riskVestergaard (2020) [46]
Some concernsVillani (2014) [23]
Some concernsVuorinen (2014) [47]
Nonrandomized studiesb
Moderate riskAmir (2017) [24]
Serious riskBakhshi (2011) [42]
Critical riskEilat-Tsanani (2015) [45]
Serious riskKoulaouzidis (2019) [28]
Critical riskMaeng (2014) [30]
Critical riskPark (2019) [40]
Moderate riskRiley (2015) [41]
Serious riskVan der Burg (2020) [34]
Critical riskVeenstra (2015) [35]
Serious riskWare (2020) [36]
Serious riskWhite-Williams (2015) [4]
Moderate riskWilliams (2016) [37]
Serious riskZan (2015) [38]
aAssessed using Cochrane risk-of-bias tool for randomized trials.
bAssessed using Risk of Bias in Non-randomized Studies of Interventions tool.
Effects of Telemonitoring on Health Care Utilization
Overview
Telemonitoring studies used many different outcome measures,
the most common of which were hospitalizations, ED visits,
and health care costs. Whereas some studies report the effects
of telemonitoring on specific CHF outcomes, for example, heart
failure readmissions, other studies only report the effect on
all-cause health care utilization. The type of analysis and effect
measures differed widely among studies, with hazard ratios,
odds ratios, 2-tailed t tests, and incidence rates being reported.
Table 4 shows the (statistically significant) effects of
telemonitoring on health care utilization.
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eIndicates statistically significant (P<.05) reduction in outcome measure.
fIndicates not statistically significant (P>.05) on outcome measure.
gAnalysis based on the comparison between Motiva and Motiva plus.
hIndicates statistically significant (P<.05) increase in outcome measure.
iAnalysis based on intention-to-treat analysis.
jAnalysis based on matched-cohort analysis.
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Hospitalization was the most commonly reported outcome
(24/29, 83% of studies). Out of 24 studies, 9 (38%) showed a
statistically significant reduction in hospitalizations associated
with telemonitoring. The remaining studies (15/24, 63%) found
no effect on hospitalization. When excluding all studies with a
high, critical, or serious risk of bias (n=11), 31% (4/13) of
studies reported a statistically significant reduction in
hospitalizations [23,24,31,43]. Although the number of studies
reporting a statistically significant effect was limited, the effects
found in these studies were clinically relevant. Amir et al [24]
reported a temporary reduction of hospitalizations of 87% during
the intervention. However, hospitalization increased by 79%
when the intervention ended. Delaney et al [43] found that
hospitalization rates were 19% and 38% in the intervention and
control groups, respectively. Pedone et al [31] reported an
incidence rate of 0.30 (95% CI 0.12-0.67), favoring the
intervention group. Villani et al [23] found that the control group
had almost twice the number of hospitalizations compared with
the intervention group. We did not find a parameter in the study
characteristics that consistently differed from the other studies
that showed no effect of telemonitoring.
ED Visits
In total, 8 studies reported results related to the number of ED
visits [4,21-23,33,36,38,45]; 7 (88%) reported no statistically
significant effects of telemonitoring and 1 (13%) found a
significant effect, reporting 17 ED visits in the control group
(n=40) compared with 6 ED visits in the intervention group
(n=40) [23].
Length of Stay
The outcome measure length of stay was reported in 4 studies
[21,33,36,42]. None of the included studies found a statistically
significant effect of telemonitoring on the length of stay.
Days of Hospitalization
Days of hospitalization were reported in 10 studies, of which 8
(80%) reported on all-cause days of hospitalization and 5 (50%)
on days of hospitalization specifically for heart failure. There
were 2 studies that showed a reduction in all-cause days of
hospitalization [34,45]. The 2 studies showing a decrease in
heart failure–related days of hospitalization did not result in a
statistically significant decrease in all-cause days of
hospitalization [28,39].
Visits
A total of 9 studies reported outcome measures related to
non-ED health care visits. These visits comprised outpatient
visits [20,22,23,26,36,45,47], primary care visits [33,45], home
visits by nurse [37,45], urgent care visits [33], and telephone
contacts [47]. Most (6/9, 67%) of these studies found that their
telemonitoring intervention was associated with a significant
increase in non-ED health care visits [22,23,26,33,37,47]. A
total of 2 studies found no difference [36,45], and 1 study [20]
found a decrease in non-ED visits for heart failure specifically.
However, this reduction of heart failure rates did not result in
a statistically significant decrease in the number of visits. Two
studies were considered as having a critical [45] or serious risk
of bias [36]. Both of these studies reported no effect of
telemonitoring on non-ED visits.
Health Care Costs
A comparison of health care costs between the intervention and
control groups was performed in 10 studies. Out of these 10, 3
(30%) studies showed a decrease in costs [30,34,46], 4 (40%)
studies showed no statistically significant difference
[20,33,39,44], and 3 (30%) studies showed a negative impact
of telemonitoring on health care costs [23,32,37]. Two studies,
which we assessed as having a serious or critical risk of bias,
reported statistically significant decreases in health care costs
[30,34]. When a decrease in costs was realized by the
telemonitoring program, this was mainly due to a reduction in
hospitalizations or rehospitalizations [30,34]. In addition to a
reduction in hospitalizations, Vestergaard et al [46] found a
reduction in outpatient care costs in the telemonitoring group.
Furthermore, 3 studies finding a reduction of health care costs
reported 11% [30], 35% [46], and 90% [34] reductions in health
care costs. When telemonitoring was associated with an increase
in costs, this was due to an increase in outpatient visits [37], an
overall increase in health care utilization [32], or the costs of
the telemonitoring program itself [23].
Six studies included and explicitly mentioned the costs of (the
development of) the intervention in their analyses
[20,23,30,32,37,46]. These studies reported large differences
in the costs of the intervention, mostly due to cointerventions
and specific assumptions regarding program and development
costs. Multimedia Appendix 5 [20,23,30,32,37,46] provides a
description of the costs. In the study by Villani et al [23], a
reduction in hospitalization costs could not offset the additional
costs of the intervention. This indicates a substantial influence
of program costs in determining the cost-effectiveness of
telemonitoring programs. An important factor for cost
differences was the high cost of developing a telemonitoring
program for a selected population.
Discussion
Principal Findings
The goal of this review was to identify the broad impact and
various aspects of telemonitoring programs for patients with
CHF and their effects on health care utilization. Most studies
showed no statistically significant effects of telemonitoring on
overall hospitalizations (14/21, 67%), ED visits (7/8, 88%),
length of stay (4/4, 100%), and days of hospitalization (6/8,
75%). However, the remaining studies showed reductions in
health care utilization for these measures. Overall, non-ED
outpatient visits and health care costs were increased in 67%
(6/9) of studies and 30% (3/10) of studies, respectively. The
most ambiguously reported health care utilization measure was
health care costs, which showed increases in 30% (3/10) of the
studies, decreases in 30% (3/10) of the studies, and no
differences in 40% (4/10) of the studies. Heart failure–specific
health care utilization measures showed similar results as the
overall health care utilization measures.
We found a high degree of clinical diversity among the
interventions, in terms of physiological parameters as well as
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the targeted populations. Although most telemonitoring
programs were targeted at patients in NYHA Classes II-III, a
variety of additional inclusion criteria were used. In addition to
clinical diversity, methodological heterogeneity was also high,
as can be observed by the varying risk of bias assessments.
Some of the studies included in this review suggested that
telemonitoring may result in lower hospital admission rates, but
most studies did not report such reductions. This mixed effect
is consistent with the current literature [10,48]. In addition, we
found no clear associations between the extracted study
characteristics and the effect of telemonitoring and a reduction
in hospitalizations. However, we found that 67% (6/9) of studies
reported an increase in non-ED outpatient visits when
telemonitoring was used.
Thus far, the effect of telemonitoring on non-ED visits has
received little attention. However, the early warning designs of
telemonitoring might also attract additional use of frontline
services and false-positive alarms. An overview of systematic
reviews [11] showed that 2 of 19 systematic reviews included
non-ED visits in their outcomes [49,50]. These systematic
reviews included 5 studies, 1 [51] of which can be classified as
telemonitoring based on our definition. This RCT showed a
substantial increase in non-ED visits and phone calls for
telemonitoring compared with usual care. Our results suggest
that this may be the case for most telemonitoring programs, as
we found that 67% (6/9) of studies showed an increase in
non-ED visits. One study found a decrease in heart
failure–related non-ED visits. This study [20] explicitly stated
that “patients allocated to the intervention group were only
allowed to visit the cardiologist or HF-nurse in case of an
absolute need for intervention.” In addition, 83% (5/6) of
studies, which found an increase in visits, had telemonitoring
as an additional component in addition to usual care
[22,26,37,47], and 17% (1/6) did not state this explicitly [33].
This stresses the need to treat telemonitoring as a substitute for
regular care, rather than an addition to regular care, that is, if a
reduction in health care utilization is the primary aim. Five
studies reported an increase in non-ED visits and hospitalizations
as outcome measures. Villani et al [23] found an increase in
non-ED visits simultaneously with a reduction in
hospitalizations. The other 4 studies [22,26,33,37] reported an
increase in non-ED visits and found no effect on hospitalization.
This indicates that additional visits can be a side effect of
telemonitoring rather than a prerequisite for effective
telemonitoring programs in terms of reduced health care
utilization. Therefore, telemonitoring programs may become
more cost-effective if they pay more attention to decreasing
these visits.
The effect of telemonitoring on health care costs has been
inconsistent across studies. Health care costs were severely
affected by the costs of telemonitoring programs, which showed
large differences. These differences were attributable to both
assumptions regarding the development costs per patient and
the actual cost differences. These cost differences can have a
detrimental effect on the cost-effectiveness and financial
viability of the program. No studies included indirect cost
savings or expenses from a patient perspective, such as a
reduction or increase in travel costs.
Strength and Limitations
A major strength of our study is the inclusion of various study
designs and outcome measures for health care utilization.
Therefore, this review offers a broader scope than other reviews
[11]. The inherent weakness of including nonrandomized studies
was the introduction of biases because of case mixes. This was
demonstrated by the results of the Risk of Bias in
Non-randomized Studies of Interventions tool, which showed
a high degree of bias in the domain of baseline confounding.
The exclusion of studies also using STS within their
telemedicine program resulted in the exclusion of a significant
number of studies. However, the exclusion of these studies also
increases the relevance of our study for those interested in the
stand-alone effect of telemonitoring on health care utilization.
The main limitation of this review is the lack of a meta-analysis
and thus a limited ability to draw strong conclusions regarding
the effect of telemonitoring on health care utilization. However,
this review clearly shows why meta-analyses are difficult to
perform on this subject and, if performed, should be interpreted
with caution. We observed high heterogeneity within the study
populations, telemonitoring programs, and outcomes. Therefore,
a meta-analysis was not appropriate for this study. In addition,
the results of meta-analyses of other studies may only be
applicable to small subsets of populations, interventions, and
outcomes and thus may not represent the true effect of
telemonitoring on health care utilization because of limited
external validity.
Implications for Practice
This study has several practical implications. The finding that
telemonitoring often increases non-ED visits has consequences
for the workload of outpatient clinics. These additional non-ED
visits may occur because of a variety of reasons such as false
positives, true positives, equipment malfunction, and whether
telemonitoring is used as additional or substitute care. Detecting
true positives is the primary aim, as it prevents more expensive
health care utilization and improves the quality of life. Although
false-positive alerts and equipment malfunctions may be reduced
by improving technology and algorithms [52], our results
suggest that addition instead of substitution is likely to remain,
resulting in additional non-ED visits. Health care providers must
be aware of this increase and adopt organizational structure of
the outpatient clinic or find other ways to mitigate this increase,
such as using telemonitoring as a substitute rather than additional
care [20] or outsourcing technical difficulties experienced by
patients to medical service centers [34].
This review showed that telemonitoring might shift health care
utilization to outpatient settings, as opposed to only reducing
inpatient admissions. This may complicate adoption, as the
benefits may not be attributable to the same stakeholder as the
costs. This is especially the case for health care systems where
outpatient care is delivered by organizations other than inpatient
care, such as that of Germany. In such cases, conflicting interests
are to be expected, and health care payers have to come to an
agreement with health care providers to overcome these issues
[53]. Health care regulators can facilitate this process by creating
and supporting new payment models such as shared savings
and lump-sum payment models.
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Finally, the high costs of developing telemonitoring programs
for a selected population can diminish and even cancel future
monetary gains of reduced health care consumption [23]. One
way of suppressing the costs of telemonitoring can be achieved
through the use and development on a larger scale. Villani et
al [23] showed that developing a telemonitoring system for 40
patients was not financially viable. In contrast, Vestergaard et
al [46] reduced the costs of the program per patient by targeting
a larger population, namely a whole region of North Denmark
constituting 6700 patients. Health care providers should either
use the scale realized by a third party or codevelop
telemonitoring systems with other health care providers to
realize possible scale advantages. In addition, in general,
substitutive programs are expected to achieve higher financial
savings.
Future Research
Future studies should consider clinical diversity by including
subgroup meta-analyses or performing meta-regression, as
opposed to pooled meta-analyses [54]. As mentioned previously,
we found a high degree of clinical and methodological diversity
[54]. Despite this, some meta-analyses [48,55] have found a
low to moderate effect for certain health care utilization
measures. The presence of high clinical diversity and low
statistical heterogeneity may be due to minimal marginal effects
of components in the telemonitoring program; a part of the
intervention did not affect the outcome measure. If this is the
case, certain (combinations of) telemonitoring components do
not add value to the intervention. Yun et al [56] and Kotb et al
[57] performed such analyses on all-cause mortality and
hospitalization in patients with CHF. Certain program
characteristics, such as having 3 or more physiological
parameters [56] or including an electrocardiograph [57], were
statistically associated with a reduction in all-cause mortality
and hospitalization, respectively. Similarly, essential and
effective parts of telemonitoring for reducing other health care
utilization can be identified, thereby supporting the development
of (cost-) effective telemonitoring programs. Clear descriptions
of the intervention and context are needed to perform such
analyses. This review can be used as guidance for forming
subgroups or variables of interest for meta-regressions. As there
are many more factors that may affect the impact of
telemonitoring on health care utilization, qualitative research
may be used to develop hypotheses and guide meta-regression
protocols.
Conclusions
This review investigated the effects of telemonitoring programs
on different aspects of health care utilization. Telemonitoring
has the potential to reduce hospitalization rates. However, this
was not achieved in most studies, as the number of non-ED
visits increased in the majority of studies. The effect of
telemonitoring on health care costs is highly ambiguous and
depends on the effectiveness of the intervention in reducing
health care utilization as well as on the costs of the
telemonitoring program itself. Health care providers and payers
should be aware that the majority of current telemonitoring
programs do not result in a reduction in health care utilization
and may even increase health care utilization by increasing the
number of non-ED visits. Possible payer strategies should be
focused at increasing the scale to reduce program costs and
implement telemonitoring as a substitute to reduce possible
increases in outpatient visits. Nevertheless, more focus is needed
to determine the essential factors of telemonitoring programs
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